Sentences with phrase «in vaccine science»

The latest developments in vaccine science have shown us that veterinary practices need new vaccine protocols, tailored to the lifestyle of your pet.

Not exact matches

The global demonstration, planned in the wake of the Women's March on Washington, is aimed at countering the «mischaracterization of science as a partisan issue» — see climate change, vaccines, and GMOs — and the dubious policy that has arisen as a result.

To reach the fifth child, science has found an important partner in the faith community, which helps bring vaccines to the most remote areas and the children who need them most.

We do not need to «research» every wacky idea that vaccine rejectionists devise and our refusal to «research» those ideas without basis in science or logic is not a sign that someone is hiding something.

By insisting that they are «experts,» natural childbirth advocates, vaccine rejectionists and others can simultaneously embrace the esteem in which science is viewed and reject the actual scientific evidence.

The University of California, Los Angeles — led group reported in this week's Science that they may have created the «Goldilocks» of flu vaccines — one that manages to trigger a very strong immune response without making infected animals sick.

Multiple obstacles stand in the way of this becoming a future universal flu vaccine for humans, scientists from The Scripps Research Institute cautioned in an accompanying commentary in Science.

Gosling is a senior medical writer at Novartis Vaccines and Diagnostics in Germany and freelance science writer.

Burton, along with 21 other researchers, co-authored a 2004 paper in Science criticizing the choice to proceed to phase III with two vaccines that had never demonstrated any effectiveness alone.

In the interim, doctors need to be patient but firm with fearful parents, explain why vaccines are essential and help restore the public's faith in sciencIn the interim, doctors need to be patient but firm with fearful parents, explain why vaccines are essential and help restore the public's faith in sciencin science.

According to the Washington Post, La Montagne's interest in science can be traced back to playing with a chemistry set and reading an article in Look magazine (no longer published) about a doctor who worked with vaccines.

Gosling is a senior medical writer at Novartis Vaccines & Diagnostics in Germany and also works as a freelance science writer.

• Finally, there's a surprising Science Careers connection to one of this week's biggest science stories: The malaria vaccine paper in SScience Careers connection to one of this week's biggest science stories: The malaria vaccine paper in Sscience stories: The malaria vaccine paper in ScienceScience.

His example suggests that while science's first and greatest triumph in this area was to develop vaccinations to control or eradicate many diseases, the challenge now — not yet achieved, and in some ways even more difficult — is to preserve public support for vaccine programs long after these scourges have largely vanished from our everyday lives.

So whatever your life science training, there could be a rewarding job for you in vaccine research.

«The matching process is not a perfect science, therefore, in some flu seasons, the vaccine available in the fall is not a good match for the circulating virus strains and is less effective,» said senior author David Weiner, Ph.D., Executive Vice President and Director of the Vaccine and Immune Therapy Center at The Wistar Insvaccine available in the fall is not a good match for the circulating virus strains and is less effective,» said senior author David Weiner, Ph.D., Executive Vice President and Director of the Vaccine and Immune Therapy Center at The Wistar InsVaccine and Immune Therapy Center at The Wistar Institute.

There's also a news story on the new vaccine in this week's Science, by Jocelyn Kaiser.

Gosling is a senior medical writer at Novartis Vaccines and Diagnostics in Germany and a freelance science writer.

The results of the early - stage vaccine trial suggest that the preventive treatment should be developed further and that scientists are a step closer to being able to counter a potential H7N9 flu pandemic using a clinically tested vaccine, researchers argue April 30 in Science...

A resurgence in whooping cough cases in the U.S. is likely due to incomplete vaccine coverage in the past combined with waning protection from the vaccine, according to a new study published in the March 28 issue of Science Translational Medicine.

Phase II trials for that vaccine candidate are set to begin within the next two months, so it will not likely be available to combat the current swine flu outbreak, which could kill as many as 90,000 Americans and land up to 1.8 million in the hospital, according to the President's Council of Advisors on Science and Technology (PCAST).

This article appears in the October 28, 2017 issue of Science News with the headline,» One and done: A universal flu vaccine might be nearing reality.»

To prosper in such an environment, a scientist must recognize that science alone does not influence policy, such as availability of a vaccine.

In this circumstance, it is easier to continue believing that autism and vaccines are linked, according to Dartmouth College political science researcher Brendan Nyhan.

In 2011, Science's editors will be watching a smaller detector at the Large Hadron Collider called LHCb, which will study B mesons in great detail; new techniques that should lead to the discovery of many more genes contributing to adaptation; an ignited fusion burn at the National Ignition Facility; broadly neutralizing antibodies, which are capable of disabling a wide range of viral variants; the first plug - in hybrid electric cars whose batteries are charged from a wall socket go on the market; and the results of the first phase III trial of a malaria vaccinIn 2011, Science's editors will be watching a smaller detector at the Large Hadron Collider called LHCb, which will study B mesons in great detail; new techniques that should lead to the discovery of many more genes contributing to adaptation; an ignited fusion burn at the National Ignition Facility; broadly neutralizing antibodies, which are capable of disabling a wide range of viral variants; the first plug - in hybrid electric cars whose batteries are charged from a wall socket go on the market; and the results of the first phase III trial of a malaria vaccinin great detail; new techniques that should lead to the discovery of many more genes contributing to adaptation; an ignited fusion burn at the National Ignition Facility; broadly neutralizing antibodies, which are capable of disabling a wide range of viral variants; the first plug - in hybrid electric cars whose batteries are charged from a wall socket go on the market; and the results of the first phase III trial of a malaria vaccinin hybrid electric cars whose batteries are charged from a wall socket go on the market; and the results of the first phase III trial of a malaria vaccine.

«What is new about this is we have developed a vaccine against dust - mite allergens that hasn't been used before,» says Aliasger Salem, professor in pharmaceutical sciences at the UI and a corresponding author on the paper.

Science's picks for Areas to watch in 2017 are human embryo research, Zika vaccine trials, the search for Planet Nine, and the impacts on research of the U.S. election and «Brexit» vote.

Science of Health: Stamping out vaccine fears early Discussions with parents about vaccinations for their babies should take place during, or even before, pregnancy, suggest Matthew Daley and Jason Glanz in an article in this month's Scientific American.

«This nanoformulation approach allows us to make vaccines against new diseases in only seven days, allowing the potential to deal with sudden outbreaks or make rapid modifications and improvements,» says Daniel Anderson, an associate professor in MIT's Department of Chemical Engineering and a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES).

«This survey looks in - depth at people's views about vaccines to explore which groups have more reservations about the MMR vaccine and whether or not those views are connected with people's trust in medical science,» said Funk.

However, Paul Keim, acting chair of the U.S. National Science Advisory Board for Biosecurity (NSABB)-- which recommended that the mutant - flu work should not be published in full — cautions that there are not enough flu vaccines or drugs worldwide, and a rapid pandemic would overwhelm our ability to manufacture more.

The study, which was published in the last issue of Science Translational Medicine, reports early plasma cytokine signatures that correlate with, and predict, the immunogenicity and reactogenicity of the vaccine.

The finding, reported in the March 19, 2014, issue of the journal Science Translational Medicine, helps explain why a combination of two vaccines was able to show some effect, when one vaccine alone did not.

«Using an experimental vaccine on human beings in the middle of an outbreak in this case would not be ethical, feasible, or wise,» a WHO representative e-mailed Science on 16 July.

For this survey of global health, Science has joined forces with Science Translational Medicine, which examines vaccine development, strategies against emerging infections, progress in point - of - care diagnostics, and ways to promote mental health and neonatal health.

Her book The Vaccine Race: Science, Politics and the Human Costs of Defeating Disease (Viking, 2017) will be out in paperback in February.

The only approved vaccine for dengue may actually increase the incidence of dengue infections requiring hospitalization rather than preventing the disease if health officials aren't careful about where they vaccinate, new public health research published Sept. 2 in Science suggests.

As another paper published yesterday, this one in Science Express, emphasizes yet again, widespread use of a vaccine could have a powerful impact against the H1N1 virus — if it arrived early enough and was widely used.

Several less aggressive vaccine candidates are waiting in the wings (Science, 20 December 2002, p. 2314).

This work, published in the scientific journal Nature Medicine, was carried out in collaboration with researchers at the Scripps Research Institute in La Jolla and the Center for infectious disease research in Seattle and was partially funded by the Swiss National Science Foundation (SNSF), the European Research Council (ERC), Swiss Vaccine Research Institute and the Fondazione Aldo e Cele Daccò.

In those days, the Salk polio vaccine, hailed as deliverance from the dreaded scourge that crippled and killed thousands of children every year, ranked as the hottest thing in medical sciencIn those days, the Salk polio vaccine, hailed as deliverance from the dreaded scourge that crippled and killed thousands of children every year, ranked as the hottest thing in medical sciencin medical science.

Gosling is a senior medical writer at Novartis Vaccines and Diagnostics in Germany and also works as a freelance science writer.

Reported in the January 16, 2015 issue of the journal Science, the new findings provide a cautionary tale for the development of vaccines aimed at eliciting robust CD4 T cell immunity against chronic infections, including HIV.

If these genes were highly active before vaccination, an individual would generate a high level of antibodies after vaccination, no matter the flu strain in the vaccine, researchers report online August 25 in Science Immunology.

A 2013 paper in STM by another group, documenting a different type of vaccine - triggered autoimmune re action, was retracted after the results proved irreproducible (Science, 1 August 2014, p. 498).

When they heard about the rise in narcolepsy in 2010, neuroscientist Lawrence Steinman of Stanford University in Palo Alto, California, and rheumatologist Sohail Ahmed, who at the time was global head of clinical sciences at Novartis's vaccines and diagnostics division in Siena, Italy, began scouring databases for proteins expressed in the brain that might resemble those in the vaccine.

See all of Science's coverage of the Ebola outbreak, including stories from survivors Nancy Writebol and Senga Omeonga, the tough choices ahead in vaccine development, and hope for controlling the disease in Liberia.

See all of Science's coverage of the Ebola outbreak, including the Ebola vaccine, the U.N. Security Council's historic resolution to confront the disease, and the situation on the ground in Liberia.

In one of the greatest moments in modern medical science, American microbiologist Jonas Salk on 12 April 1955 pronounced his newly invented polio vaccine safe and effective in almost 90 % of caseIn one of the greatest moments in modern medical science, American microbiologist Jonas Salk on 12 April 1955 pronounced his newly invented polio vaccine safe and effective in almost 90 % of casein modern medical science, American microbiologist Jonas Salk on 12 April 1955 pronounced his newly invented polio vaccine safe and effective in almost 90 % of casein almost 90 % of cases.

A study published 2 years ago in Science suggested the strategy might work: It showed that a neoantigen vaccine stimulated immune responses in three advanced melanoma patients who had already received a cancer drug.